Grail (GRAL) Interest & Investment Income (2023 - 2026)
Grail's (GRAL) quarterly Interest & Investment Income came in at $7.2 million in Q2 2026, up 6.18% on a YoY basis from $6.8 million in Q2 2025, and down 9.47% quarter-over-quarter from $8.0 million in Q1 2026.
Analysis
Grail (GRAL) Interest & Investment Income (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Interest & Investment Income for 4 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 6.18% year-over-year to $7.2 million; the trailing twelve-month figure through Jun 2026 stood at $29.3 million (down 17.79% YoY), and the FY2025 full-year result was $28.7 million, up 7.18% from the prior year.
- Interest & Investment Income fell to $7.2 million in Q2 2026 per GRAL's latest filing, from $8.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $11.7 million in Q3 2024 and bottomed at $1.4 million in Q4 2023.
- Historically, Interest & Investment Income has averaged $5.9 million across 4 years, with a median of $6.8 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income surged 593.26% in 2024, then tumbled 47.63% in 2025.
- Over 4 years, Interest & Investment Income stood at $1.4 million in 2023, then soared by 593.26% to $9.4 million in 2024, then fell by 15.04% to $8.0 million in 2025, then retreated by 9.14% to $7.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $7.2 million, $8.0 million, and $8.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -63.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 5.60 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 10.20 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 3.90 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 6.82 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -34.41 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 4.69 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 2.26 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 7.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.23 Mn |
| Mar 31, 2026 | 7.99 Mn |
| Dec 31, 2025 | 7.96 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 6.81 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 9.37 Mn |
| Sep 30, 2024 | 11.66 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Oct 1, 2023 | 2.53 Mn |
| Jun 30, 2023 | 1.85 Mn |